The Drug Discovery Center at the Genome Research Institute, University of Cincinnati, is collaborating with Genedata on high-throughput screening (HTS). The centre will use the latter's Genedata Screener, an open and scalable enterprise solution for HTS and high-content screening (HCS), which will be integrated into the centre's HTS workflows.
The Drug Discovery Center is working on molecular probes for application in the pharmaceutical and biotech industries and needed a software solution to manage and analyse its small molecule screening campaigns. The Screener platform combines enterprise-wide assay data management with high-performance processing workflows and flexible analysis tools to rapidly analyse, integrate and manage all assay data, independent of instrumentation, technology, volume or location.
'The Screener system from Genedata matched our screening and analysis workflows and is easy to use. Users can start working with Screener on the fly and need very little additional IT support,' explained Dr Sandra Nelson, director of HTS and Research Associate Professor at the University of Cincinnati. 'Another key feature for us is the automated quality control, which has reduced analysis and review time from days to mere hours per screen.'
